Damya Laoui, Kiavash Movahedi, Eva Van Overmeire, Jan Van den Bossche, Elio Schouppe, Camille Mommer, Alexandros Nikolaou, Yannick Morias, Patrick De Baetselier, Jo A. Van Ginderachter. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. In press Int. J. Dev. Biol.

Geert Raes, Patrick De Baetselier, Jo A. Van Ginderachter Meeting report: Clinical and fundamental aspects of monocyte, macrophage and dendritic cell plasticity. In press Eur. J. Immunol.

Luyckx A, Schouppe E, Rutgeerts O, Lenaerts C, Koks C, Fevery S, Devos T, Dierickx D, Waer M, Van Ginderachter JA, Billiau AD. Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice. Bone Marrow Transplant. 2011 Oct 31. doi: 10.1038/bmt.2011.207. [Epub ahead of print]

Laoui D, Van Overmeire E, Movahedi K, Van den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, De Baetselier P, Van Ginderachter JA. Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. Immunobiology. 2011 Nov;216(11):1192-202. Epub 2011 Jun 30.

De Vocht C, Ranquin A, Van Ginderachter J, Vanhaecke T, Rogiers V, Van Gelder P, Versées W, Steyaert J. Polymeric nanoreactors for enzyme replacement therapy of MNGIE. J Control Release. 2010 Nov 20;148(1):e19-20. No abstract available.

Laoui D, Van Overmeire E, Movahedi K, Van den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, De Baetselier P, Van Ginderachter JA. Mononuclear phagocyte heterogeneity in cancer: Different subsets and activation states reaching out at the tumor site. Immunobiology. 2011 Jun 30.

Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Knevels E, Costa S, Vinckier S, Dresselaer T, Åkerud P, De Mol M, Salomäki H, Phillipson M, Wyns S, Larsson E, Buysschaert I, Botling J, Himmelreich U, Van Ginderachter JA, De Palma M, Dewerchin M, Claesson-Welsh L, Carmeliet P. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell. 2011 Jan 18;19(1):31-44.